XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 26, 2025
Sep. 27, 2024
Sep. 26, 2025
Sep. 27, 2024
Income Statement [Abstract]        
Net sales $ 444,808 $ 436,715 $ 1,296,796 $ 1,247,868
Cost of sales 358,685 355,777 1,051,836 1,014,859
Gross margin 86,123 80,938 244,960 233,009
Selling, general, and administrative expense 38,256 35,009 108,740 104,454
Research and development expense 6,548 7,868 19,466 22,712
Restructuring expense 212 1,493 2,729 6,161
Other—net 6,164 5,309 15,068 14,112
Operating profit 34,943 31,259 98,957 85,570
Other non-operating (income)—net (711) (642) (1,944) (1,925)
Interest expense—net 7,544 8,839 22,691 25,920
Income before income taxes 28,110 23,062 78,210 61,575
Income tax expense 2,698 768 9,960 6,836
Net income $ 25,412 $ 22,294 $ 68,250 $ 54,739
Basic earnings per share:        
Net income per share of common stock (in dollars per share) $ 1.23 $ 1.07 $ 3.29 $ 2.64
Diluted earnings per share:        
Net income per share of common stock (in dollars per share) $ 1.22 $ 1.07 $ 3.27 $ 2.61
Weighted-average number of shares of common stock outstanding:        
Basic (in shares) 20,731 20,749 20,763 20,723
Diluted (in shares) 20,883 20,920 20,893 20,935